Kappaproct
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Kappaproct, covering 2018-01-24 to 2018-01-24. Get the full timeline:
Most recent: Clinical Trial Update: The Efficacy and Safety of Cobitolimod (Kappaproct®) in Chronic Active Treatment Refractory Ulcerative Colitis Patients [Phase 3]